Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Sensitivity of PET/MR images in liver metastases from colorectal carcinoma.

Yong TW, Yuan ZZ, Jun Z, Lin Z, He WZ, Juanqi Z.

Hell J Nucl Med. 2011 Sep-Dec;14(3):264-8.

PMID:
22087447
2.

Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.

Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D.

J Nucl Med. 2010 May;51(5):692-9. doi: 10.2967/jnumed.109.068510. Epub 2010 Apr 15.

3.

Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.

Schraml C, Schwenzer NF, Sperling O, Aschoff P, Lichy MP, Müller M, Brendle C, Werner MK, Claussen CD, Pfannenberg C.

Cancer Imaging. 2013 Mar 5;13:63-72. doi: 10.1102/1470-7330.2013.0007.

4.

Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.

Cantwell CP, Setty BN, Holalkere N, Sahani DV, Fischman AJ, Blake MA.

J Comput Assist Tomogr. 2008 Sep-Oct;32(5):738-44. doi: 10.1097/RCT.0b013e3181591d33.

PMID:
18830103
5.
6.
7.

Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentation.

Bagci U, Kramer-Marek G, Mollura DJ.

EJNMMI Res. 2013 Jul 5;3(1):49. doi: 10.1186/2191-219X-3-49.

8.

Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.

Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, Stoker J.

Radiology. 2005 Oct;237(1):123-31. Epub 2005 Aug 11.

PMID:
16100087
9.

Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.

Grueneisen J, Nagarajah J, Buchbender C, Hoffmann O, Schaarschmidt BM, Poeppel T, Forsting M, Quick HH, Umutlu L, Kinner S.

Invest Radiol. 2015 Aug;50(8):505-13. doi: 10.1097/RLI.0000000000000197.

PMID:
26115367
10.

Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?

Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA.

Ann Surg. 2004 Dec;240(6):1027-34; discussion 1035-6.

11.

Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.

Rappeport ED, Loft A, Berthelsen AK, von der Recke P, Larsen PN, Mogensen AM, Wettergren A, Rasmussen A, Hillingsoe J, Kirkegaard P, Thomsen C.

Acta Radiol. 2007 May;48(4):369-78.

PMID:
17453514
12.

Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of (18)F-FDG PET/CT and MR imaging.

Maegerlein C, Fingerle AA, Souvatzoglou M, Rummeny EJ, Holzapfel K.

Abdom Imaging. 2015 Jun;40(5):1213-22. doi: 10.1007/s00261-014-0283-x.

PMID:
25348732
13.

Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases.

Coenegrachts K, De Geeter F, ter Beek L, Walgraeve N, Bipat S, Stoker J, Rigauts H.

Eur Radiol. 2009 Feb;19(2):370-9. doi: 10.1007/s00330-008-1163-y. Epub 2008 Sep 16.

PMID:
18795299
14.

Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.

Bacigalupo L, Aufort S, Eberlé MC, Assenat E, Ychou M, Gallix B.

Radiol Med. 2010 Oct;115(7):1087-100. doi: 10.1007/s11547-010-0560-x. Epub 2010 Jun 23. English, Italian.

PMID:
20574703
15.

The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion.

Salem S, Houseni M, Zidan L, Kandil A.

Nucl Med Biol. 2015 Jul;42(7):637-42. doi: 10.1016/j.nucmedbio.2015.03.010. Epub 2015 Apr 6.

PMID:
25907467
16.

The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.

Boykin KN, Zibari GB, Lilien DL, McMillan RW, Aultman DF, McDonald JC.

Am Surg. 1999 Dec;65(12):1183-5.

PMID:
10597072
17.

Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.

Seemann MD, Meisetschlaeger G, Gaa J, Rummeny EJ.

Eur J Med Res. 2006 Feb 21;11(2):58-65.

PMID:
16504962
18.

PET/CT versus body coil PET/MRI: how low can you go?

Appenzeller P, Mader C, Huellner MW, Schmidt D, Schmid D, Boss A, von Schulthess G, Veit-Haibach P.

Insights Imaging. 2013 Aug;4(4):481-90. doi: 10.1007/s13244-013-0247-7. Epub 2013 May 15.

19.

Evaluation of the potential of PET-MRI fusion for detection of liver metastases in patients with neuroendocrine tumours.

Schreiter NF, Nogami M, Steffen I, Pape UF, Hamm B, Brenner W, Röttgen R.

Eur Radiol. 2012 Feb;22(2):458-67. doi: 10.1007/s00330-011-2266-4. Epub 2011 Sep 9.

PMID:
21904802
20.

Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series.

Brendle C, Schwenzer NF, Rempp H, Schmidt H, Pfannenberg C, la Fougère C, Nikolaou K, Schraml C.

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):123-32. doi: 10.1007/s00259-015-3137-z. Epub 2015 Jul 31.

PMID:
26224536
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk